A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC).

Bibliographic Details
Title: A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC).
Authors: Saltos, Andreas Nicholas, Arrowood, Christy, Beasley, Georgia, Ronald, James, El-Haddad, Ghassan, Guerra-Guevara, Luiziane, Khan, Uzma, Wolf, Steven, Gu, Lin, Wang, Xiaofei F., Foresman, Dana, Yu, Xiaoqing, Cantwell, Mark J., Antonia, Scott Joseph, Beg, Amer A, Ready, Neal E.
Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2569-2569, 1p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.2023.41.16_suppl.2569
Published in:Journal of Clinical Oncology
Language:English